Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Marguerite, Rooney"'
Autor:
Alice T. Shaw, Richard B. Lanman, Justin F. Gainor, Jochen K. Lennerz, Aaron N. Hata, Anna F. Farago, Jennifer Ackil, Emily Chin, Harper Hubbeling, Beow Y. Yeap, Rebecca J. Nagy, Jessica J. Lin, Marguerite Rooney, Ibiayi Dagogo-Jack
Purpose:Acquired resistance to next-generation ALK tyrosine kinase inhibitors (TKIs) is often driven by secondary ALK mutations. Here, we investigated utility of plasma genotyping for identifying ALK resistance mutations at relapse on next-generation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b9e48e98418d9d0fff3053feff13a86
https://doi.org/10.1158/1078-0432.c.6527913.v1
https://doi.org/10.1158/1078-0432.c.6527913.v1
Autor:
Alice T. Shaw, Richard B. Lanman, Justin F. Gainor, Jochen K. Lennerz, Aaron N. Hata, Anna F. Farago, Jennifer Ackil, Emily Chin, Harper Hubbeling, Beow Y. Yeap, Rebecca J. Nagy, Jessica J. Lin, Marguerite Rooney, Ibiayi Dagogo-Jack
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02f27b4c7b3e4183579988da58f431b5
https://doi.org/10.1158/1078-0432.22471503
https://doi.org/10.1158/1078-0432.22471503
Autor:
Alice T. Shaw, Richard B. Lanman, Justin F. Gainor, Jochen K. Lennerz, Aaron N. Hata, Anna F. Farago, Jennifer Ackil, Emily Chin, Harper Hubbeling, Beow Y. Yeap, Rebecca J. Nagy, Jessica J. Lin, Marguerite Rooney, Ibiayi Dagogo-Jack
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3384f455ea48d90cfb9e0941bd7d8887
https://doi.org/10.1158/1078-0432.22471500
https://doi.org/10.1158/1078-0432.22471500
Autor:
Alice T. Shaw, Richard B. Lanman, Justin F. Gainor, Jochen K. Lennerz, Aaron N. Hata, Anna F. Farago, Jennifer Ackil, Emily Chin, Harper Hubbeling, Beow Y. Yeap, Rebecca J. Nagy, Jessica J. Lin, Marguerite Rooney, Ibiayi Dagogo-Jack
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::332af61334b699155ec0f0395c0e64e7
https://doi.org/10.1158/1078-0432.22471506.v1
https://doi.org/10.1158/1078-0432.22471506.v1
Autor:
Kylie Prutisto Chang, Mari Mino-Kenudson, Alice T. Shaw, Adam Langenbucher, Michael S. Lawrence, Marina Kem, Pranav Gupta, Justin F. Gainor, Isobel J Fetter, Andrew Do, Satoshi Yoda, Jessica J. Lin, Ibiayi Dagogo-Jack, Audris Oh, Marguerite Rooney, Aaron N. Hata, James R. Stone, Ryan B. Corcoran, Emily Chin, Jochen K. Lennerz, Dejan Juric
Publikováno v:
npj Precision Oncology, Vol 4, Iss 1, Pp 1-8 (2020)
NPJ Precision Oncology
NPJ Precision Oncology
Histologic transformation from non-small cell to small cell lung cancer has been reported as a resistance mechanism to targeted therapy in EGFR-mutant and ALK fusion-positive lung cancers. Whether small cell transformation occurs in other oncogene-dr
Autor:
Emily Chin, Cyril H. Benes, Sara Stevens, Subba R. Digumarthy, Ashish Saxena, Alice T. Shaw, Beow Y. Yeap, Rebecca J. Nagy, Christopher G. Azzoli, Hetal D. Marble, Jessica J. Lin, Justin F. Gainor, Adam Langenbucher, Kylie Prutisto-Chang, Andrew Do, Jochen K. Lennerz, Satoshi Yoda, Nathaniel A. Adams, Marguerite Rooney, Aaron N. Hata, Michael S. Lawrence, Audris Oh, Ibiayi Dagogo-Jack
Publikováno v:
Clin Cancer Res
Purpose: Most ALK-positive lung cancers will develop ALK-independent resistance after treatment with next-generation ALK inhibitors. MET amplification has been described in patients progressing on ALK inhibitors, but frequency of this event has not b
Autor:
Tianqi Chen, Subba R. Digumarthy, Jessica J. Lin, Lecia V. Sequist, Marguerite Rooney, Alice T. Shaw, Dexter P. Mendoza
Publikováno v:
American Journal of Roentgenology. 214:766-774
OBJECTIVE. ALK rearrangements are an established targetable oncogenic driver in non–small cell lung cancer (NSCLC). The goal of this study was to determine the imaging features of the primary tumor...
Autor:
Beow Y. Yeap, Jochen K. Lennerz, Harper Hubbeling, Rebecca J. Nagy, Jennifer Ackil, Jessica J. Lin, Marguerite Rooney, Aaron N. Hata, Emily Chin, Anna F. Farago, Alice T. Shaw, Justin F. Gainor, Richard B. Lanman, Ibiayi Dagogo-Jack
Publikováno v:
Clinical Cancer Research. 25:6662-6670
Purpose: Acquired resistance to next-generation ALK tyrosine kinase inhibitors (TKIs) is often driven by secondary ALK mutations. Here, we investigated utility of plasma genotyping for identifying ALK resistance mutations at relapse on next-generatio
Autor:
Alice T. Shaw, Jochen K. Lennerz, Jessica J. Lin, Rebecca J. Nagy, Justin F. Gainor, Lorin A. Ferris, Marguerite Rooney, Richard B. Lanman, Ibiayi Dagogo-Jack, Jennifer Ackil, Emily Chin
Publikováno v:
Journal of Thoracic Oncology. 14:816-824
Introduction Circulating tumor DNA analysis is an emerging genotyping strategy that can identify tumor-specific genetic alterations in plasma including mutations and rearrangements. Detection of ROS1 fusions in plasma requires genotyping approaches t
Autor:
Ibiayi Dagogo-Jack, Anderson H. Kuo, Eric W. Zhang, Marguerite Rooney, Alice T. Shaw, Subba R. Digumarthy
Publikováno v:
CancerReferences. 126(20)
Background Plasma genotyping is an emerging approach for the identification of genetic alterations mediating resistance to anaplastic lymphoma kinase (ALK)-targeted therapy. The authors reviewed plasma genotyping and imaging findings to assess the co